SHH · 603456.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.53% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 1.28% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s next earnings report is currently expected on Apr 23, 2027, with estimated earnings per share of CN¥0.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zhejiang Jiuzhou Pharmaceutical Co., Ltd, a company established in 1973 and operating from its headquarters in Taizhou, China, specializes in the production and global supply of active pharmaceutical ingredients (APIs) and their chemical precursors. Its extensive product catalog includes APIs designed for a wide range of therapeutic applications, encompassing treatments for central nervous system disorders (such as anti-depressants and Parkinson's disease), various infectious ailments (including antiviral, general anti-infection, and specific respiratory anti-infection agents), diabetes management, non-steroidal drugs, oncological therapies, Hepatitis C, and cardiovascular conditions. Furthermore, beyond its pharmaceutical focus, the company also furnishes specialized asymmetric catalysts and crucial materials utilized in lithium-ion batteries.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥1.29B+0.04% vs estimate |
| Q2 2025 | Aug 5, 2025 | CN¥0.31+40.91% vs estimate | CN¥1.38B |
|---|
| Q1 2025 | Apr 14, 2025 | CN¥0.28+47.37% vs estimate | CN¥1.49B+0.02% vs estimate |
|---|
| Q1 2025 | Apr 10, 2025 | -CN¥0.03-115.0% vs estimate | CN¥1.20B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥8.09+CN¥0.10 (+1.25%)
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 22.66% below the high.
CN¥15.15+CN¥0.65 (+4.48%)
Guobang Pharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.25% below the high.
CN¥5.63-CN¥0.17 (-2.93%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.06% below the high.
CN¥8.92+CN¥0.06 (+0.68%)
Zhejiang Xianju Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.24% below the high.
CN¥19.95-CN¥0.10 (-0.5%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.24% below the high.
CN¥4.80+CN¥0.03 (+0.63%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.13% below the high.
CN¥21.61-CN¥0.35 (-1.59%)
Zhejiang AngLiKang Pharmaceutical CO.,LTD.’s quoted price sits in the lower half of its reported 52-week range, 55.81% below the high.
CN¥8.01-CN¥0.01 (-0.12%)
Zhejiang Starry Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.26% below the high.
